Chiara Pavanello

Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study

Tycho R. Tromp, Merel L. Hartgers, G. Kees Hovingh et al. · The Lancet · 2022 · 189 citations · Full text

Metabolic Syndrome, Lipid Disorder, Cardiovascular Disease +7

Nutraceutical approach to moderate cardiometabolic risk: Results of a randomized, double-blind and crossover study with Armolipid Plus

Massimiliano Ruscica, Monica Gomaraschi, Giuliana Mombelli et al. · Journal of clinical lipidology · 2013 · 82 citations

Obesity, Metabolic Syndrome, Heart Failure +13

Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study

Angela Pirillo, K. Garlaschelli, Marcello Arca et al. · Atherosclerosis Supplements · 2017 · 78 citations · Full text

Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study

Manuela Casula, Elena Olmastroni, Angela Pirillo et al. · Atherosclerosis · 2018 · 75 citations · Full text

Obesity, Metabolic Syndrome, Lipid Analysis +10

Efficacy of Lomitapide in the Treatment of Familial Homozygous Hypercholesterolemia: Results of a Real-World Clinical Experience in Italy

Laura D’Erasmo, Angelo B. Cefalù, Davide Noto et al. · Advances in Therapy · 2017 · 72 citations

Metabolic Syndrome, Real-world Clinical Experience, Lipid Disorder +11